Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates
about
Treatment options for central nervous system lymphomas in immunocompetent patients.Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experienceLeucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts.Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissuesIdentification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaIn vitro correlates of clinical response to methotrexate in actue leukaemia and Burkitt's lymphomaDipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue.Methotrexate and the need for continued research.The antifolatesPharmacokinetics and metabolism of methotrexate: an example for the use of clinical pharmacology in pediatric oncology.Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use.Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.Absorption of large oral doses of 5-formyltetrahydrofolate in man.Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate.Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs.The unclear role of methotrexate in the treatment of diffuse large-cell lymphoma.Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma.Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.Prolongation and enhancement of serum methotrexate concentrations by probenecid.
P2860
Q33510785-747ABF3C-BC58-4FDE-B2E6-52A317CF1878Q33859877-6F942724-37AD-4ED2-A745-90B966768395Q34403384-B516BF75-7948-43D6-8012-E62B964BF4AAQ34508535-87A85030-0244-4CC5-8783-E4546EB3603FQ35437120-A2229F5D-3AEE-44D4-9C85-C49B7EA1220FQ35678403-2D92AAAE-5A82-41D5-94F1-AE6552555956Q36068795-8181236A-9B97-4F65-AD40-98A2131A0E18Q36261677-6CFBA8B5-9846-4AE6-BBA9-1AA20E6702F6Q36467591-27E9DD3D-BAD4-4A24-BDC3-45C9ECC54A34Q36998220-1D04D4AC-7BE5-406D-8090-49D7B3D174F9Q37183495-4DFBA8ED-6D6E-4884-ACD7-96CC4682CE72Q37951561-A8CAAFC5-8455-4B0C-915C-CD47BE879B66Q39454734-A4FBE4F4-F664-44BE-81A0-6BBCA41B0D23Q39780182-B3459A30-7C95-4B81-8510-AA821B1CADE5Q42221292-952DA2B8-E283-4B31-B92A-0404AC4BE3BCQ42714104-7E7AABEF-4C9C-4323-B024-2603114CCBF1Q44054597-E5A4BE37-5124-4538-802B-63DF046EE572Q44077806-57C2E610-01AA-4424-BDA8-3A8B4882E1C7Q45030593-70EDE8D5-B6F4-4C61-BFFB-63FF68BEB053Q47883922-C75CD316-795B-4413-8F80-D0EE7E476BB6Q48117441-4F2C17A5-5FCC-4F35-A0CF-0032E155EB64Q49901693-F6F907E4-0AD3-43DA-86FE-F08DF5DED4A0
P2860
Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates
description
1969 nî lūn-bûn
@nan
1969 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1969 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1969年の論文
@ja
1969年論文
@yue
1969年論文
@zh-hant
1969年論文
@zh-hk
1969年論文
@zh-mo
1969年論文
@zh-tw
1969年论文
@wuu
name
Treatment of leukemia with lar ...... linical-biochemical correlates
@ast
Treatment of leukemia with lar ...... linical-biochemical correlates
@en
Treatment of leukemia with lar ...... linical-biochemical correlates
@nl
type
label
Treatment of leukemia with lar ...... linical-biochemical correlates
@ast
Treatment of leukemia with lar ...... linical-biochemical correlates
@en
Treatment of leukemia with lar ...... linical-biochemical correlates
@nl
prefLabel
Treatment of leukemia with lar ...... linical-biochemical correlates
@ast
Treatment of leukemia with lar ...... linical-biochemical correlates
@en
Treatment of leukemia with lar ...... linical-biochemical correlates
@nl
P2860
P356
P1476
Treatment of leukemia with lar ...... linical-biochemical correlates
@en
P2093
Bertino JR
Hryniuk WM
P2860
P304
P356
10.1172/JCI106181
P407
P577
1969-11-01T00:00:00Z